Bristol Myers (Mexico) Insiders
| BMY Stock | MXN 1,206 0.99 0.08% |
Bristol Myers employs about 41 people. The company is managed by 10 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 4.1 employees per reported executive. Break down of Bristol Myers' management performance can provide insight into the company performance.
| Ann Judge President Senior Vice President - Global Human Resources |
| Christopher Boerner President Executive Vice President and Chief Commercial Officer |
Bristol |
Bristol Myers Management Team Effectiveness
The company has return on total asset (ROA) of 0.0613 % which means that it generated a profit of $0.0613 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1846 %, meaning that it generated $0.1846 on every $100 dollars invested by stockholders. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities.Bristol Myers Workforce Comparison
Bristol Myers Squibb is rated second in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is currently estimated at about 120,230. Bristol Myers adds roughly 41.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. Bristol Myers Squibb Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bristol Myers Squibb Price Series Summation is a cross summation of Bristol Myers price series and its benchmark/peer.
Bristol Myers Notable Stakeholders
A Bristol Myers stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bristol Myers often face trade-offs trying to please all of them. Bristol Myers' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bristol Myers' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ann Judge | Senior Vice President - Global Human Resources | Profile | |
| Christopher Boerner | Executive Vice President and Chief Commercial Officer | Profile | |
| Jitendra Tyagi | Head India | Profile | |
| Cari Gallman | VP Officer | Profile | |
| David Elkins | Ex CFO | Profile | |
| BCH BM | Ex Devel | Profile | |
| Giovanni MD | Chairman CEO | Profile | |
| Greg Meyers | Ex Officer | Profile | |
| Sandra Esq | Exec Counsel | Profile | |
| Timothy Power | VP Relations | Profile |
About Bristol Myers Management Performance
The success or failure of an entity such as Bristol Myers Squibb often depends on how effective the management is. Bristol Myers management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bristol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bristol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOL MYERS operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 23300 people.
Please note, the imprecision that can be found in Bristol Myers' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bristol Myers Squibb. Check Bristol Myers' Beneish M Score to see the likelihood of Bristol Myers' management manipulating its earnings.
Bristol Myers Workforce Analysis
Traditionally, organizations such as Bristol Myers use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bristol Myers within its industry.Bristol Myers Manpower Efficiency
Return on Bristol Myers Manpower
| Revenue Per Employee | 1.1B | |
| Revenue Per Executive | 4.6B | |
| Net Income Per Employee | 154.3M | |
| Net Income Per Executive | 632.7M |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.